American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing

• Published in: Blood advances Vol. 7; no. 22; pp. 7101 - 7138
• Main Authors: Middeldorp, Saskia, Nieuwlaat, Robby, Baumann Kreuziger, Lisa, Coppens, Michiel, Houghton, Damon, James, Andra H., Lang, Eddy, Moll, Stephan, Myers, Tarra, Bhatt, Meha, Chai-Adisaksopha, Chatree, Colunga-Lozano, Luis E., Karam, Samer G., Zhang, Yuan, Wiercioch, Wojtek, Schünemann, Holger J., Iorio, Alfonso
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 28.11.2023; The American Society of Hematology
• Subjects: Anticoagulants - therapeutic use; Antithrombins - therapeutic use; Clinical Guidelines; Female; Hematology; Humans; Pregnancy; Thrombophilia - diagnosis; Thrombophilia - etiology; United States; Venous Thromboembolism - diagnosis; Venous Thromboembolism - drug therapy; Venous Thromboembolism - etiology; United States

Hereditary and acquired thrombophilia are risk factors for venous thromboembolism (VTE). Whether testing helps guide management decisions is controversial. These evidence-based guidelines from the American Society of Hematology (ASH) intend to support decision making about thrombophilia testing. ASH...